IBERDOMIDE

Search structure
Synonyms:
Status: Phase 2
Entry Type: Small molecule
Molecule Category: UNKNOWN
UNII: 8V66F27X44

Structure
InChI Key IXZOHGPZAQLIBH-NRFANRHFSA-N
Smile O=C1CC[C@H](N2Cc3c(OCc4ccc(CN5CCOCC5)cc4)cccc3C2=O)C(=O)N1
InChI
InChI=1S/C25H27N3O5/c29-23-9-8-21(24(30)26-23)28-15-20-19(25(28)31)2-1-3-22(20)33-16-18-6-4-17(5-7-18)14-27-10-12-32-13-11-27/h1-7,21H,8-16H2,(H,26,29,30)/t21-/m0/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C25H27N3O5
Molecular Weight 449.51
AlogP 1.86
Hydrogen Bond Acceptor 6.0
Hydrogen Bond Donor 1.0
Number of Rotational Bond 6.0
Polar Surface Area 88.18
Molecular species NEUTRAL
Aromatic Rings 2.0
Heavy Atoms 33.0

Pharmacology

Action Mechanism of Action Reference
MODULATOR CRL4(CRBN) E3 ubiquitin ligase modulator PubMed PubMed PubMed
Targets EC50(nM) IC50(nM) Kd(nM) Ki(nM) Inhibition(%)
Unclassified protein
1 60-16000 - 4940 -

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Multiple Myeloma 2 D009101 ClinicalTrials
Renal Insufficiency 1 D051437 ClinicalTrials

Related Entries

Scaffolds

Cross References

Resources Reference
ChEMBL CHEMBL3989927
DrugBank DB12101
FDA SRS 8V66F27X44
Guide to Pharmacology 9618
PDB 8W7
PubChem 67335295
SureChEMBL SCHEMBL2252414
ZINC ZINC000118417658
CONTENTS